Search filters

List of works by Ralf Ketter

AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry

scientific article published on 6 October 2013

CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas

scientific article published on 08 July 2020

Chordoid meningiomas can be sub-stratified into prognostically distinct DNA methylation classes and are enriched for heterozygous deletions of chromosomal arm 2p

scientific article published on 31 October 2018

Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1

scientific article published on 14 December 2020

Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial

scientific article published on 27 January 2016

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis

scientific article published on 14 March 2017

DNA methylation-based classification of central nervous system tumours

scientific article published on 14 March 2018

Deletions in the 17q chromosomal region and their influence on the clonal cytogenetic evolution of recurrent meningiomas

scientific article published on 24 May 2019

Importance of biomarkers in glioblastomas patients receiving local BCNU wafer chemotherapy

scientific article published on 4 May 2017

Incidence, mortality and outcome of meningiomas: A population-based study from Germany

scientific article published on 17 July 2019

Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide

scientific article published on July 2016

MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial

scientific article published on 5 February 2015

Mutational patterns and regulatory networks in epigenetic subgroups of meningioma

scientific article published on 08 May 2019

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide

scientific article published on 9 November 2009

Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation

scientific article published on 25 September 2013

Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations

scientific article

TERT Promoter Mutations and Risk of Recurrence in Meningioma

scientific article published on 13 December 2015

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

scientific article

The Influence of Distinct Regulatory miRNAs of the p15/p16/RB1/E2F Pathway on the Clinical Progression of Glioblastoma Multiforme

scientific article published on 24 July 2019

Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade

scientific article